TY  - JOUR
AU  - Castilla-Guerra, L
AU  - Fernández-Moreno, M C
AU  - Rico-Corral, M A
PY  - 2017
DO  - 10.1016/j.nrl.2017.03.009
UR  - http://hdl.handle.net/10668/11245
T2  - Neurologia (Barcelona, Spain)
AB  - Proprotein convertase subtilisin/kexin type 9 (PCSK9) plays an important role in the modulation of plasma levels of low density lipoprotein cholesterol (LDLC). PCSK9 binds to the LDL receptor (LDLR), disrupts its endocytic recycling itinerary and...
LA  - en
KW  - Cholesterol
KW  - Colesterol
KW  - Ictus
KW  - Inhibidores de PCSK9
KW  - LDL
KW  - PCSK9 inhibitors
KW  - Prevención
KW  - Prevention
KW  - Pro-protein convertase subtilisin kexine type 9
KW  - Proproteína convertasa subtilisina kexina tipo 9
KW  - Stroke
KW  - Antibodies, Monoclonal
KW  - Antibodies, Monoclonal, Humanized
KW  - Anticholesteremic Agents
KW  - Cholesterol, LDL
KW  - Humans
KW  - PCSK9 Inhibitors
KW  - Proprotein Convertase 9
KW  - Receptors, LDL
KW  - Stroke
TI  - Cholesterol and stroke: Roll of PCSK9 inhibitors.
T2  - Colesterol e ictus: papel de los inhibidores de la proproteína convertasa subtilisina/kexina tipo 9.
TY  - research article
VL  - 34
ER  -